NCT03737734View on ClinicalTrials.gov

Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)

NAActive, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2018

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Interventions
DEVICE

Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)

An intratumoral insertion of a seed(s), loaded with Radium-224, securely fixed in the seeds. The seeds release by recoil into the tumor short-lived alpha-emitting atoms.

Trial Locations (1)

49100

Davidof Cancer Institution at the Rabin Medical Center Israel, Petah Tikva

Sponsors
All Listed Sponsors
lead

Alpha Tau Medical LTD.

INDUSTRY